Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Ended earlyNCT03875495
What this trial is testing

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Who this might be right for
Multiple Myeloma
Genenta Science 9
Not applicableLooking for participantsNCT05259553
What this trial is testing

Biomarkers in Multiple Myeloma

Who this might be right for
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Centre Hospitalier Universitaire de Saint Etienne 70
Early research (Phase 1)Study completedNCT00088101
What this trial is testing

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+1 more
Synta Pharmaceuticals Corp. 42
Not applicableEnded earlyNCT01616537
What this trial is testing

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter

Who this might be right for
Malignant Mast Cell TumorsSolid Organ Sites
Centre Antoine Lacassagne 990
Not applicableStudy completedNCT00367588
What this trial is testing

Low Bacterial Diet in Patients With Cytopenia

Who this might be right for
Cytopenia
Maastricht University Medical Center 20
Early research (Phase 1)Study completedNCT00904787
What this trial is testing

Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed or Refractory Hematological Malignancies
CASI pharmaceuticals, Inc. 27
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Not applicableUnknownNCT05099237
What this trial is testing

Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester

Who this might be right for
Colorectal CancerLung CancerHematological Cancer+1 more
Manchester University NHS Foundation Trust 80
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Not applicableStudy completedNCT01669005
What this trial is testing

The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies

Who this might be right for
Neutropenia
Centre Hospitalier Universitaire Vaudois 84
Testing effectiveness (Phase 2)Ended earlyNCT00781781
What this trial is testing

Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning

Who this might be right for
Graft Versus Host Disease
CABYC 34
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Post-approval studies (Phase 4)Study completedNCT01114165
What this trial is testing

Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients

Who this might be right for
Hematologic DiseasesNeutropeniaFebrile Neutropenia+1 more
University Hospital Muenster 150
Not applicableStudy completedNCT06573307
What this trial is testing

Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy

Who this might be right for
Gastric Cancer
Chang-Ming Huang, Prof. 442
Post-approval studies (Phase 4)Not Yet RecruitingNCT07474961
What this trial is testing

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

Who this might be right for
Waldenstrom MacroglobulinaemiaMultiple Myeloma
Anne Louise Tølbøll Sørensen 400
Testing effectiveness (Phase 2)WithdrawnNCT01554254
What this trial is testing

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Who this might be right for
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT03605212
What this trial is testing

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Who this might be right for
Tumor Lysis Syndrome
Menarini Group 30
Testing effectiveness (Phase 2)Study completedNCT01474681
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Next Page